Cardiovascular disease (CVD) is the leading cause of mortality globally. In the past several
decades, researchers have raised significant awareness about the sex differences in CVD …

Background Whether the antiinflammatory and immunomodulatory effects of glucocorticoids
may decrease mortality among patients with severe community-acquired pneumonia is …

Despite its prominence in early scientific records, the usefulness of saliva as a respiratory
specimen has been de-emphasised over the past century. However, due to its low cost and …

Background Lower respiratory infections (LRIs) cause a substantial mortality, morbidity and
economic burden. The present study reported the global, regional and national burden of …

Although adverse environmental exposures are considered a major cause of chronic
diseases, current studies provide limited information on real-world chemical exposures and …

Respiratory viruses including the respiratory syncytial virus (RSV) aggravate the global
burden of virus-inflicted morbidity and mortality. Entry inhibitors are a promising class of …

Particulate matter (PM) air pollution is closely related to lower respiratory infections (LRIs).
However, the global LRI burden attributable to PM remains unclear. Here, we provide a …

Summary Background Lower respiratory infections (LRIs) are a major global contributor to
morbidity and mortality. In 2020–21, non-pharmaceutical interventions associated with the …

Acute respiratory infections (ARI), especially lower respiratory infections (LRI), are a leading
cause of childhood morbidity and mortality globally. Non-pharmaceutical interventions (NPI) …

Lower respiratory infections (LRIs) are a major killer globally, especially at the extremes of
age—bron chiolitis in young children and pneumonia in all ages are the main contributors to …